DGM / GM - Portfolio & Business Development (US) Sterile Formulations

Role & responsibilities

AGM / DGM / GM Portfolio & Business Development (US)

• Develop and execute an integrated strategy for sterile product portfolio management and commercial growth, aligned with Antheas long-term business objectives.
• Identify and evaluate new product opportunities and lifecycle extension strategies based on market trends, regulatory developments, and therapeutic needs across key regions.
• Lead the assessment and prioritization of new pipeline projects in coordination with R&D, Regulatory Affairs, and Commercial teams, ensuring scientific, technical, and market viability.
• Drive business development initiatives by identifying and pursuing B2B Out-Licensing, Contract Manufacturing (CMO), and Contract Development & Manufacturing (CDMO) opportunities in the US and other regulated markets.
• Manage and optimize the product lifecycle of sterile/injectable products - from early-stage opportunity evaluation through development, registration, launch, commercialization, and sunsetting.
• Lead deal-making processes including partner scouting, due diligence, commercial negotiations, contract structuring, and ongoing alliance management.
• Conduct comprehensive market and competitive analyses to inform both portfolio decisions and external business development strategies.
• Collaborate with internal cross-functional teams (R&D, Operations, Regulatory, Legal, Supply Chain) to ensure seamless execution of product and partnership strategies.
• Maintain up-to-date knowledge of global regulatory environments (e.g., FDA, EMA), ensuring compliance is embedded in all portfolio and business development activities.
• Build and maintain strong relationships with current and prospective partners, including pharmaceutical companies, CDMOs, licensing partners, and development collaborators.
• Represent Anthea at industry conferences, global trade shows, and networking events to enhance visibility, promote capabilities, and generate new business leads.

Deliver strategic insights and periodic reports to senior management on portfolio performance, market dynamics, pipeline progress, and partnership opportunities.

Preferred candidate profile

• MBA with

  12 to 18+ years

  of combined experience in

  pharmaceutical portfolio management and business development

  , specifically within the

  sterile/injectables segment

• Strong understanding of

  regulated markets

  , particularly the

  US FDA

  , and global pharmaceutical regulatory landscapes
• Proven success in managing

  product lifecycles

  , launching new products, and building

  strategic partnerships

• Demonstrated ability to lead complex

  deal negotiations

  and drive successful collaborations in B2B and CDMO/CMO contexts